Eder IE - Search Results

1

Glycoprofiling of proteins as prostate cancer biomarkers: A multinational population study.

Pinkeova A, Tomikova A, Bertokova A, Fabinyova E, Bartova R, Jane E, Hroncekova S, Sievert KD, Sokol R, Jirasko M, Kucera R, Eder IE, Horninger W, Klocker H, Ďubjaková P, Fillo J, Bertok T, Tkac J. Pinkeova A, et al. Among authors: eder ie. PLoS One. 2024 Mar 18;19(3):e0300430. doi: 10.1371/journal.pone.0300430. eCollection 2024. PLoS One. 2024. PMID: 38498504 Free PMC article.

2

Targeting the androgen receptor in hormone-refractory prostate cancer--new concepts.

Eder IE, Haag P, Bartsch G, Klocker H. Eder IE, et al. Future Oncol. 2005 Feb;1(1):93-101. doi: 10.1517/14796694.1.1.91. Future Oncol. 2005. PMID: 16555979 Review.

3

Lovastatin causes diminished PSA secretion by inhibiting AR expression and function in LNCaP prostate cancer cells.

Yang L, Egger M, Plattner R, Klocker H, Eder IE. Yang L, et al. Among authors: eder ie. Urology. 2011 Jun;77(6):1508.e1-7. doi: 10.1016/j.urology.2010.12.074. Urology. 2011. PMID: 21624609

4

In vitro model systems to study androgen receptor signaling in prostate cancer.

Sampson N, Neuwirt H, Puhr M, Klocker H, Eder IE. Sampson N, et al. Among authors: eder ie. Endocr Relat Cancer. 2013 Mar 26;20(2):R49-64. doi: 10.1530/ERC-12-0401. Print 2013 Apr. Endocr Relat Cancer. 2013. PMID: 23447570 Review.

5

Novel therapeutic approaches for the treatment of castration-resistant prostate cancer.

Heidegger I, Massoner P, Eder IE, Pircher A, Pichler R, Aigner F, Bektic J, Horninger W, Klocker H. Heidegger I, et al. Among authors: eder ie. J Steroid Biochem Mol Biol. 2013 Nov;138:248-56. doi: 10.1016/j.jsbmb.2013.06.002. Epub 2013 Jun 20. J Steroid Biochem Mol Biol. 2013. PMID: 23792785 Free PMC article. Review.

6

Emerging promising biomarkers for treatment decision in metastatic castration-resistant prostate cancer.

Kafka M, Eder IE, Klocker H, Heidegger I. Kafka M, et al. Among authors: eder ie. Urol Oncol. 2020 Nov;38(11):801-815. doi: 10.1016/j.urolonc.2020.05.025. Epub 2020 Jun 24. Urol Oncol. 2020. PMID: 32591248 Review.

7

Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP-dependent protein kinase A.

Desiniotis A, Schäfer G, Klocker H, Eder IE. Desiniotis A, et al. Among authors: eder ie. Int J Cancer. 2010 Feb 1;126(3):775-89. doi: 10.1002/ijc.24806. Int J Cancer. 2010. PMID: 19653278 Free article.

8

Gene therapy strategies in prostate cancer.

Eder IE, Haag P, Bartsch G, Klocker H. Eder IE, et al. Curr Gene Ther. 2005 Feb;5(1):1-10. doi: 10.2174/1566523052997424. Curr Gene Ther. 2005. PMID: 15638707 Review.

9

Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor.

Hobisch A, Eder IE, Putz T, Horninger W, Bartsch G, Klocker H, Culig Z. Hobisch A, et al. Among authors: eder ie. Cancer Res. 1998 Oct 15;58(20):4640-5. Cancer Res. 1998. PMID: 9788616

10

Genes differentially expressed in prostate cancer.

Eder IE, Bektic J, Haag P, Bartsch G, Klocker H. Eder IE, et al. BJU Int. 2004 May;93(8):1151-5. doi: 10.1111/j.1464-410X.2004.04869.x. BJU Int. 2004. PMID: 15142130 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page